The role of stromal cells in basic fibroblast growth factor (FGF) supply for endometrial neovascularization during the menstrual cycle was investigated. The concentrations of intracellular and secreted FGF, and FGF mRNA expression were determined in fibroblasts derived from uterine endometrium as a substitute for stromal cells. The influence of sex steroids on protein and mRNA expression was investigated.
Generally, the turnover of capillary endothelial cells is extremely slow, in the order of months or years in physiological neovascularization, while the turnover in uterine endometrium is rapid during the ovarian steroidal cycle. I Specifically, the endothelial cells are renewed from degenerated coiled arteries, migrate, and form microvessel tubes in the endometria during the early proliferative stage of menstruation.? Then, the endometrial capillary network is renewed up to the late proliferative phase, and the main arteries are coiled due to their rapid growth."
In tumour situations, the steps in neovascularization involve the following events: the basement membrane of endothelial cells is dissolved by proteases released from the tumour or host cells activated by tumour-derived angiogenic factors; and migration, proliferation and microvessel tube formation of endothelial cells follows.' Fibroblast growth factor (FGF) from tumour cells induces the expression of urokinase-type plasminogen activator and its receptor in endothelial cells, which might be related paracrinologically to dissolution of the Correspondence: Jim Fujimoto Mlll'hIJ. basement membrane of endothelial cells." Basic FGF has been cloned as a growth factor for endothelial cells derived from tumour cells.! Basic FGF induces the expression of integrin (X2fJI, with adherent potencies for collagen and laminin, and capillary tube formation." Therefore, basic FGF could contribute to some steps of neovascularization.
Uterine endometrial neovascularization is regulated by basic FGF in the endometrium, consisting of endothelial and stromal cells, during the menstrual cycle," prompting us to investigate sex steroidal regulation of basic FGF. The concentrations of intracellular and secreted FGF and its messenger ribonucleic acid (mRNA) expression were measured in endometrial fibroblasts as a substitute for stromal cells under the influence of oestradiol and/or progesterone.
MATERIALS AND METHODS

Chemicals
Oestradiol-17fJ and progesterone were purchased from Sigma Chemical Co (St Louis, MO, USA). All other chemicals and reagents were of experimental grade. These hormones were solubilized in ethanol, and added to the culture media to obtain a final concentration of ethanol below 0·1 %.
Preparation of fibroblasts derived from the endometria Human endometria were obtained from patients ranging in age from 31 to 44 years with a regular menstrual cycle who underwent hysterectomy for the treatment of uterine leiomyoma at the Department of Obstetrics and Gynecology, Gifu University School of Medicine, from March 1994 to May 1995. Informed consent was obtained from all patients.
Fetal bovine serum (FBS) was treated with 10% dextran-coated charcoal (DCC) for 16 h to remove all free steroids, and all media were phenol red-free. The endometria obtained were immediately washed with phosphate buffer solution containing amphotericin B (1'5/lg/mL) and kanamycin (60/lg/mL), and minced with a scalpel. The minced tissue, in Eagle's minimum essential medium [MEM (Nissui Pharm, Tokyo, Japan)] with 0·25% tryspin, was blended for 20 min and then repeatedly pipetted to make a cell suspension. After addition of FBS to the cell suspension to inactivate trypsin, dispersed cells were obtained. The cells were cultured in MEM with amphotericin B and kanamycin overnight, and then the floating cells were discarded. Spindle-shaped cells usually grew in a sheet-like manner, and occupied a whole square of the culture flask. After the thirteenth or fourteenth passage, enriched collagen type I was still detected in these spindle cells using a universal streptavidin/biotin immunoperoxidase detection system (Lipshaw, Pittsburgh, PA, USA) with anti-human collagen type I mouse antibody (Fuji Chemical Industries, Toyama, Japan), which indicated they were fibroblasts derived from the endometrium.
Fibroblasts were cultured in 90% Eagle's MEM and 10% FBS treated with DCC. In the present study, fibroblasts of the thirteenth or fourteenth passage were used. In each experiment, the fibroblasts (l0 7 cells in a 60 mm-petri dish) were incubated in FBS-free conventional media with oestradiol, oestradiol plus progesterone, or progesterone at final concentrations of lO-IZ to 10-6 M for the times indicated.
Enzyme immunoassay for determination of human basic FGF antigen All steps were carried out at 4°C, except where indicated. The culture supernatant was collected Ann Clin Biochem 1997: 34 and then the fibroblasts (wet weight: IG-20mg) were homogenized in 800/lL HG buffer (5 mM Tris-HCI, pH 7-4, 5 mM NaCI, 1 mM CaCI 2 2 mM ethyleneglycol-bis-Iji-aminoethyl ether)-N,N,N',N'-tetraacetic acid, I mM MgCl z, 2mM dithiothreitol (DIT), 25/lg/mL aprotinin, and 25/lg/mL leupeptin) in a Polytron homogenizer (Kinematics, Luzern, Switzerland). This suspension was centrifuged in a microfuge at 12 000 rpm for 3 min to remove the nuclear pellet from the cell lysate. The protein concentration of samples was measured by the Bradford method" to standardize the basic FGF antigen concentration, and had less than 5% variation in each petri dish.
Basic FGF antigen concentrations in the cell lysate (not diluted) and the culture medium (not diluted; total volume of the culture medium is 3 mL in a 60 mm-petri dish) from the fibroblasts treated with sex steroids were determined by an enzyme-linked imrnunosorbent assay using a BIOTRAK kit (Amersham Life Science, Amersham, UK). The concentrations of basic FGF expressed in the fibroblasts and secreted to the culture medium were standardized against the corresponding cellular protein concentrations.
Reverse transcription-polymerase chain reaction (RT-peR) to amplify basic FGF mRNA Total RNA was isolated from the cells by the acid guanidium thiocyanate-phenol-chloroform extraction method." Total RNA (3/lg) was reverse transcribed with Moloney murine leukemia virus reverse transcriptase (MMLV-RTase, 200 units, Gibco BRL, Gaitherburg, MD, USA) in 20mM Tris-HCI, pH 8-4, 50mM KCI, 2'5mM MgCl z, 0·1 mg/ml bovine serum albumin, 10 mM DTT, and 0·5 mM deoxynucleotides to generate cDNAs using random hexamer (50 ng, Gibeo BRL) at 37°C for 60 min. The RT reaction mixture was heated at 94°C for 5 min to inactivate MMLV-RTase For basic FGF mRNA, PCR, consisting of I min at 94°C for denaturation, I min at 55°C for annealing, and I min at noc for extension, was done with reverse transcribed cDNA and O'I/lM specific primers using an lWAKI thermal sequencer TSR-300 (lwaki Glass, Tokyo, Japan), with Vent DNA polymerase (New England Biolabs, Beverly, MA, USA) in lOmM KCI, 20mM Tris-HCl, pH8'8, 10mM (NH4hS04, 2 mM MgS0 4, 0·1 % Triton X-IOO and 0·15 mM deoxynucleotide phosphates for 25 cycles. PCR for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as an internal standard was simultaneously done in the same manner as that described for basic FGF mRNA.
The oligodeoxynucieotides of specific primers in PCR were synthesized according to the published information (eDNA for basic FGFs and GAPDHIO) as follows:
Sense primer for basic FGF mRNA: S'-CCAAG CGGCTGTACTGCAAA-3'(exon 1) Antisense primer for basic FGF mRNA: S'-TCC TTGACCGGTAAGTATIG-3'(exon 3) Sense primer for GAPDH mRNA: S'-TGAAG GTCGGAGTCAACGGATTIGGT-3'(exon 2) Antisense primer for GAPDH mRNA: S'-CAT GTGGGCCATGAGGTCCACCAC-3'(exon 8)
Southern blot analysis for quantities of basic FGF mRNA expression PCR products were applied to 1·2% agarose gel, and electrophoresis was done at 50-100 V. PCR products were capillary-transferred to Immobi-Ion transfer membrane (Millipore Corp, Bedford, MA, USA) for 16 h. The membrane was dried at 80°C for 30 min, and was ultra violet-irradiated to tightly fix the PCR products. The PCR products on the membrane were prehybridized in 1M NaCl, 50mM Tris-HCl, pH 7,6, and I % sodium dodecyl sulphate at 42"C for I h, and hybridized in the same solution with the biotinylated oligodeoxynucieotide probes synthesized from the sequences of the genes between the specific primers at 65°C overnight. Specific bands hybridized with the biotinylated probes were detected with Plex Luminescent Kits (Millipore Corp), and X-ray films were exposed to the membranes at room temperature for 10 min. The quantification of the Southern blot was done with Bio Image (Millipore, Ann Arbor, MI, USA). The intensity of specific bands of basic FGF mRNA was normalized with that of GAPDH mRNA. The concentration of basic FGF mRNA in the fibroblasts without treatments was assigned as an arbitrary unit/GAPDH mRNA (AUI GAPDH).
Statistical analysis was by Student's t-test: differences were considered significant when P was less than 0·05.
RESULTS
The dose-dependent effects of oestradiol on intracellular and secreted FGF and its mRNA expression in endometrial fibroblasts, incubated with oestradiol for 48 h is shown in Fig. I .
Oestradiol up to a concentration of 10-8 M significantly increased (P < 0,05) both protein and mRNA expression.
The effects of progesterone on the oestradiolinduced increase in protein and mRNA in endometrial fibroblasts, incubated for 48 h is shown in Fig. 2 . Progesterone up to a concentration of 10-6 M significantly reduced Oestradiol significantly increased (P < 0'05) basic FGF concentrations in the culture media and the fibroblasts starting at 6 hand 3 h, respectively, and its mRNA levels starting at 12 h ( Fig. 3) . Progesterone significantly decreased (P<O·05) the oestradiol-induced Increases ( Fig. 3 ).
DISCUSSION
Menstrual bleeding from arterioles occurs after the contraction of coiled arteries in uterine endometrium. Afterwards, the capillary network is renewed up to the late proliferative phase as neovascularization.' Basic FGF might contribute to some steps of neovascularization.t" Some reports state that endometrial expression of basic FGF is not altered during the menstrual cycle. 11 , 12 However, oestradiol enhances the expression of basic FGF in rat uterus." The concentration of basic FGF and its mRNA expression in the endometrium are higher at the proliferative phase than at the secretory phase, and oestradiol dipropionate administration increases basic FGF expression in the endometrium at the secretory phase. I Therefore, basic FGF synthesis in uterine endometrium might be partly regulated by ovarian steroids.
In the present study, since the trypan blue dye exclusion test demonstrated that all fibroblasts were viable, the presence of basic FGF in the culture medium and the expression of its mRNA in the fibroblasts indicated basic FGF secretion from the fibroblasts. There is no classical signal peptide in the basic FGF mclecule.r':" so the present results suggest an alternative pathway for basic FGF secretion is present in fibroblasts. 14 . 15 The secretion of basic FGF to the fibroblast culture medium was significantly increased by oestradiol, whilst progesterone diminished the oestradiol-induced increases. The effect of progesterone on oestradiol-induced basic FGF synthesis might be similar to the anti-oestrogenic potential of progesterone on various oestrogeninducible oncogene expressions (c-fos, e-jun'" and c-Ha-ras'Ti in endometrial fibroblasts, but this molecular mechanism of progesterone is still unknown. Therefore, basic FGF secretion from uterine stromal cells themselves might be partly regulated by ovarian steroids, and the function of stromal cells is considered to be active for neovascularization during the menstrual cycle, because the fibroblasts derived from uterine endometrium are thought to reliably represent the stromal cells.
In conclusion, basic FGF synthesis in uterine endometrium for neovascularization during the menstrual cycle might be regulated by sex steroids, plausibly, in part, from endometrial stromal cells through paracrine cell-to-cell interaction. 
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